Regeneron: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter earnings of $1.16 billion.

The Tarrytown, New York-based company said it had profit of $10.19 per share. Earnings, adjusted for one-time gains and costs, came to $11.86 per share.

The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $10.43 per share.

The biopharmaceutical company posted revenue of $3.43 billion in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $3.26 billion.

For the year, the company reported profit of $3.95 billion, or $34.77 per share. Revenue was reported as $13.12 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN

Advertisement

Recommended Stories